1. Home
  2. PCT vs CNTA Comparison

PCT vs CNTA Comparison

Compare PCT & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PureCycle Technologies Inc.

PCT

PureCycle Technologies Inc.

HOLD

Current Price

$12.89

Market Cap

2.3B

Sector

Utilities

ML Signal

HOLD

Logo Centessa Pharmaceuticals plc

CNTA

Centessa Pharmaceuticals plc

HOLD

Current Price

$39.75

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCT
CNTA
Founded
2015
2020
Country
United States
United Kingdom
Employees
174
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
6.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PCT
CNTA
Price
$12.89
$39.75
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$13.00
$43.17
AVG Volume (30 Days)
4.9M
1.1M
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.13
EPS
N/A
N/A
Revenue
N/A
$15,000,000.00
Revenue This Year
$380.44
N/A
Revenue Next Year
$203.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.93
$10.95
52 Week High
$17.37
$40.26

Technical Indicators

Market Signals
Indicator
PCT
CNTA
Relative Strength Index (RSI) 75.32 70.34
Support Level $12.81 $39.36
Resistance Level $13.29 $39.86
Average True Range (ATR) 0.85 0.09
MACD 0.08 -0.19
Stochastic Oscillator 90.02 68.75

Price Performance

Historical Comparison
PCT
CNTA

About PCT PureCycle Technologies Inc.

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.

Share on Social Networks: